Showing results (141-150 of 1,273) with videos related to
Sort By:
Pageof 128
Veterinary and Comparative Oncology|January 13, 2012
Nuclear morphometry in cytological specimens of canine ceruminous adenomas and carcinomasR SimeonovVeterinary and Comparative Oncology|January 13, 2012
Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranibJ de Vos, S Ramos Vega, E Noorman, et al.Veterinary and Comparative Oncology|January 13, 2012
Outcome in dogs with surgically resected oral fibrosarcoma (1997-2008)S A Frazier, S M Johns, J Ortega, et al.Veterinary and Comparative Oncology|January 13, 2012
Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcomaC F Saba, D M Vail, D H ThammVeterinary and Comparative Oncology|January 13, 2012
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumoursC London, T Mathie, N Stingle, et al.Veterinary and Comparative Oncology|January 13, 2012
Thymidine kinase assay in canine lymphomaJ W Elliott, P Cripps, L BlackwoodVeterinary and Comparative Oncology|January 13, 2012
Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell linesE L Seiser, R Thomas, K L Richards, et al.Veterinary and Comparative Oncology|August 19, 2011
Generation of recombinant antibody fragments that target canine dendritic cells by phage display technologyJ Fitting, D Killian, C Junghanss, et al.Veterinary and Comparative Oncology|November 15, 2011
Prognostic value of regional lymph node status in canine mammary carcinomasM Szczubiał, W ŁopuszynskiVeterinary and Comparative Oncology|April 17, 2014
Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia(®) ) in tumour-bearing dogs: a phase I dose-finding studyX Pan, K Tsimbas, I D Kurzman, et al.Pageof 128